Funder: National Institutes of Health (NIH)
Due Dates: October 17, 2025 | May 15, 2026 | February 17, 2027 | February 17, 2028
Funding Amounts: Up to $275,000 in direct costs over 2 years; no more than $200,000 in any single year.
Summary: Supports exploratory and early-stage research to develop methods or agents targeting undruggable classes relevant to intractable human diseases.
Key Information: Clinical trials are not allowed; projects focused primarily on cancer are not responsive.